# Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

> **NCT07513116** · NA · NOT_YET_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 20 (estimated)

## Conditions studied

- Evaluating
- Intermittent Fasting
- Pancreatic Cancer

## Interventions

- **OTHER:** intermittent fasting

## Key facts

- **NCT ID:** NCT07513116
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-17
- **Primary completion:** 2027-03-30
- **Final completion:** 2029-03-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07513116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07513116, "Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07513116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*